Brief: Fate Therapeutics Appoints Brian T. Powl As Chief Commercial Officer
30/06/2022 21:23
June 30 (Reuters) - Fate Therapeutics Inc FATE.O :
* FATE THERAPEUTICS APPOINTS BRIAN T. POWL AS CHIEF
COMMERCIAL
OFFICER
Source text for Eikon: ID:nGNX2yKNyD
Further company coverage: FATE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fate Therapeutics
See all newsBrief: Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial Of FT819 For The Treatment Of Lupus Nephritis
Fate Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Fate Therapeutics Q2 loss narrows as expenses fall, revenue rises
Fate Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview
Fate Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview